January 2025

Kyle McElearney is a Director Process Development in the Pivotal Drug Substance Biologics organization at Amgen’s Thousand Oaks, CA site. He leads an organization of ~30 staff across the Thousand Oaks campus and Cambridge, MA site. His organization is responsible for late-stage process development including commercial process development and process characterization for cell culture and downstream processes. His team is also responsible for commercialization of these biologics including authoring of regulatory documents and life cycle management. In...Read more

Sachin Mittal, PhD, is an Executive Director in the Pharmaceutical Sciences & Clinical Supply department at Merck Research Laboratories at Merck & Co., Inc., Rahway, NJ, USA He has more than 20 years of experience in the pharmaceutical industry, during which he has taken positions of increasing responsibility leading teams across all modalities (small molecule, biologics, vaccines) in the area of sterile drug product development and commercialization. Currently, he heads the Vaccine Drug Product Development team at Merck that is responsible for...Read more